{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:53:57Z","timestamp":1781607237889,"version":"3.54.5"},"reference-count":314,"publisher":"Elsevier","isbn-type":[{"value":"9780128245675","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.pbr.2021.01.004","type":"book-chapter","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T04:14:30Z","timestamp":1611288870000},"page":"135-175","source":"Crossref","is-referenced-by-count":9,"title":["Serotonin 2A receptors and cannabinoids"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pbr.2021.01.004_bb0010","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1523\/JNEUROSCI.1090-09.2009","article-title":"PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors","volume":"29","author":"Abbas","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.schres.2011.04.007","article-title":"Epigenetic dysregulation of 5-HTR2A in the brain of patients with schizophrenia and bipolar disorder","volume":"129","author":"Abdolmaleky","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0074-7742(06)78005-9","article-title":"Alterations of serotonin transmission in schizophrenia","volume":"78","author":"Abi-Dargham","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0025","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41386-020-0690-3","article-title":"\u03949-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial","volume":"45 (11)","author":"Adam","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0030","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1021\/ja01865a083","article-title":"Structure of cannabinol. III. Synthesis of ccannabinol, 1-hydroxy-3-n-amyl-6,6,9-trimethyl-6-dibenzopyran","volume":"62","author":"Adams","year":"1940","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0035","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.161.3842.706","article-title":"Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe","volume":"161","author":"Aghajanian","year":"1968","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0040","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopsych.2009.03.012","article-title":"The serotonin-1A receptor in anxiety disorders","volume":"66","author":"Akimova","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0045","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia. A longitudinal study of Swedish conscripts","volume":"2","author":"Andr\u00e9asson","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0050","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/0024-3205(89)90278-6","article-title":"Identification of fatty acid amides in human plasma","volume":"45","author":"Arafat","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0091-3057(01)00578-0","article-title":"Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters","volume":"70","author":"Ar\u00e9valo","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","article-title":"Causal association between cannabis and psychosis: examination of the evidence","volume":"184","author":"Arseneault","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0065","first-page":"65","article-title":"Cannabinoids for the treatment of neuropathic pain: clinical evidence","volume":"9","author":"Ashton","year":"2008","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","article-title":"Endocannabinoid system dysfunction in mood and related disorders","volume":"124","author":"Ashton","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0075","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1471-4159.2009.06025.x","article-title":"Lack of CB 1 receptor activity impairs serotonergic negative feedback","volume":"109","author":"Aso","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0080","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/npp.2014.334","article-title":"Endocannabinoid signaling within the basolateral amygdala integrates multiple stress hormone effects on memory consolidation","volume":"40","author":"Atsak","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuint.2007.07.008","article-title":"CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus","volume":"52","author":"Bal\u00e1zsa","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0095","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0100","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/npp.2010.80","article-title":"Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus","volume":"35","author":"Bambico","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pnpbp.2012.02.006","article-title":"Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission","volume":"38","author":"Bambico","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.euroneuro.2015.12.027","article-title":"The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A\/C activity in the hippocampus","volume":"26","author":"Bambico","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0115","first-page":"120","article-title":"A high-resolution in vivo atlas of the human brain's serotonin system","volume":"37","author":"Beliveau","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0125","first-page":"177","article-title":"A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial","volume":"14","author":"Berk","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by \u03949-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0135","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1523\/JNEUROSCI.0678-08.2008","article-title":"Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses","volume":"28","author":"Best","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0140","doi-asserted-by":"crossref","first-page":"34614","DOI":"10.1074\/jbc.M404673200","article-title":"Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected G\u03b1q-coupled protein receptors","volume":"279","author":"Bhatnagar","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0145","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of \u0394-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0150","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0155","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s40265-019-01132-x","article-title":"Cannabinoids: current and future options to treat chronic and chemotherapy-induced neuropathic pain","volume":"79","author":"Blanton","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bcp.2018.06.025","article-title":"Appraising the \u201centourage effect\u201d: antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer","volume":"157","author":"Blasco-Benito","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0170","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1073\/pnas.95.8.4102","article-title":"Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide","volume":"95","author":"Boger","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0175","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.pbb.2004.02.020","article-title":"Functional responses to the cannabinoid agonist WIN 55,212-2 in neonatal rats of both genders: influence of weaning","volume":"78","author":"Borcel","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0180","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress","volume":"62","author":"Bortolato","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2010.02.013","article-title":"Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities","volume":"80","author":"Bosier","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/bs.pbr.2021.01.004_bb9313","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archpsyc.1990.01810140081011","article-title":"Sensorimotor gating and schizophrenia: human and animal model studies","volume":"47","author":"Braff","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2006.10.038","article-title":"5-HT1A receptors are involved in the anxiolytic effect of \u03949-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague\u2013Dawley rats","volume":"555","author":"Braida","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0195","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0893-133X(96)00053-X","article-title":"5-HT(1A) 5-HT(2A) receptor mRNAs and binding site densities are differentially altered in schizophrenia","volume":"15","author":"Burnet","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2017.206","article-title":"CB1 receptor signaling in the brain: extracting specificity from ubiquity","volume":"43","author":"Busquets-Garcia","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0210","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0215","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1523\/JNEUROSCI.22-16-06846.2002","article-title":"Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase C-dependent mechanism","volume":"22","author":"Carr","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0220","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.npp.1300621","article-title":"Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin","volume":"30","author":"Carter","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pnpbp.2012.01.008","article-title":"Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders","volume":"38","author":"Carvalho","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0230","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","article-title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction","volume":"57","author":"Caspi","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2051-0","article-title":"Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice","volume":"214","author":"Cassano","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnint.2013.00025","article-title":"Serotonin modulation of cortical neurons and networks","volume":"7","author":"Celada","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00406-019-00983-5","article-title":"New trends in cannabis potency in USA and Europe during the last decade (2008\u20132017)","volume":"269","author":"Chandra","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0255","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1038\/sj.npp.1395332","article-title":"Serotonin and stress","volume":"21","author":"Chaouloff","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0260","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0265","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0028-3908(98)00208-1","article-title":"Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors","volume":"38","author":"Cheer","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0270","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/01.RES.0000216858.04599.e1","article-title":"Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization","volume":"98","author":"Cogolludo","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0275","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00210830","article-title":"Central serotonin receptors: effector systems, physiological roles and regulation","volume":"92","author":"Conn","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00401509","article-title":"A possible correlation between drug-induced hallucinations in man and a behavioural response in mice","volume":"11","author":"Corne","year":"1967","journal-title":"Psychopharmacologia"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0285","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/npp.2015.53","article-title":"\u03949-THC disrupts gamma (\u03b3)-band neural oscillations in humans","volume":"40","author":"Cortes-Briones","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0290","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.bjp.0704651","article-title":"The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro","volume":"135","author":"Coyne","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0295","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.7770779","article-title":"Chemical characterization of a family of brain lipids that induce sleep","volume":"268","author":"Cravatt","year":"1995","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0300","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbr.2017.07.016","article-title":"5-Hydroxytryptamine 2A receptors of the dorsal raphe nucleus modulate panic-like behaviours and mediate fear-induced antinociception elicited by neuronal activation in the central nucleus of the inferior colliculus","volume":"357\u2013358","author":"da Silva Soares","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0305","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0091-3057(00)00477-9","article-title":"Cannabinoids of diverse structure inhibit two DOI-induced 5-HT2A receptor-mediated behaviors in mice","volume":"68","author":"Darmani","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0310","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s007020070043","article-title":"Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB 1 receptor antagonist SR 141716A in naive mice","volume":"107","author":"Darmani","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0315","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0091-3057(90)90098-3","article-title":"Do functional relationships exist between 5-HT1A and 5-HT2 receptors?","volume":"36","author":"Darmani","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0320","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0091-3057(03)00150-3","article-title":"Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover","volume":"75","author":"Darmani","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0325","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/0006-2952(84)90699-3","article-title":"Evidence for functional 5-HT2 receptor sites on human blood platelets","volume":"33","author":"De Clerck","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0330","doi-asserted-by":"crossref","first-page":"107967","DOI":"10.1016\/j.neuropharm.2020.107967","article-title":"Constitutive activity of 5-HT receptors: factual analysis","volume":"168","author":"De Deurwaerd\u00e8re","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0335","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0340","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.neuroscience.2006.02.024","article-title":"Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates","volume":"140","author":"De Jes\u00fas","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0345","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbr.2017.01.053","article-title":"Atypical antipsychotic clozapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of DOI into the inferior colliculus in rats","volume":"325","author":"de Oliveira","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0350","first-page":"121","article-title":"Cannabinoids modulate potassium current in cultured hippocampal neurons","volume":"1","author":"Deadwyler","year":"1993","journal-title":"Receptors Channels"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2003.01693.x","article-title":"The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice","volume":"85","author":"Dean","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0360","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.schres.2008.06.011","article-title":"Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia","volume":"104","author":"Dean","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0365","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.schres.2007.10.013","article-title":"Increased levels of serotonin2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic\/mutant mice","volume":"99","author":"Dean","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0370","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0375","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0380","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0385","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.116.232561","article-title":"Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway","volume":"358","author":"Dhopeshwarkar","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0390","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0395","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fphar.2016.00415","article-title":"Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex","volume":"7","author":"Diez-Alarcia","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0400","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0405","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction","volume":"57","author":"D'Souza","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0410","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of \u0394-9-tetrahydrocannabinol in frequent users of cannabis","volume":"33","author":"D'Souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0415","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/npp.2012.8","article-title":"Dose-related modulation of event-related potentials to novel and target stimuli by intravenous \u03b4 9-THC in humans","volume":"37","author":"D'Souza","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0420","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.phrs.2016.09.021","article-title":"Increasing spinal 5-HT 2A receptor responsiveness mediates anti-allodynic effect and potentiates fluoxetine efficacy in neuropathic rats. Evidence for GABA release","volume":"118","author":"Dupuis","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0425","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s002130050585","article-title":"Agonist activity of LSD and lisuride at cloned 5HT(2A) and 5HT(2C) receptors","volume":"136","author":"Egan","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0430","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-2999(02)01755-7","article-title":"Involvement of 5-hydroxytryptamine neuronal system in \u03949-tetrahydrocannabinol-induced impairment of spatial memory","volume":"445","author":"Egashira","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0435","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","article-title":"Chemical constituents of marijuana: the complex mixture of natural cannabinoids","volume":"78","author":"ElSohly","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0440","first-page":"1","article-title":"Phytochemistry of Cannabis sativa L","volume":"103","author":"ElSohly","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0445","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0450","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0893-133X(00)00163-9","article-title":"Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors: ontogeny and strain differences","volume":"23","author":"Farid","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0455","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1046\/j.1460-9568.2003.02607.x","article-title":"Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats","volume":"17","author":"Fattore","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0460","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1073\/pnas.87.6.2187","article-title":"Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis","volume":"87","author":"Felder","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0465","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0470","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.pain.2014.05.005","article-title":"Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats","volume":"155","author":"Feng","year":"2014","journal-title":"Pain"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0475","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1476-5381.1978.tb09756.x","article-title":"Antagonism of the effects on thermoregulation of \u03949-tetrahydrocannabinol by clomipramine in the rat","volume":"63","author":"Fennessy","year":"1978","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0480","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuint.2012.05.009","article-title":"Presynaptic CB1 cannabinoid receptors control frontocortical serotonin and glutamate release\u2014species differences","volume":"61","author":"Ferreira","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0485","doi-asserted-by":"crossref","first-page":"G877","DOI":"10.1152\/ajpgi.00435.2001","article-title":"5-HT2A receptors: location and functional analysis in intestines of wild-type and 5-HT2A knockout mice","volume":"282","author":"Fiorica-Howells","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0490","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00210-010-0517-6","article-title":"Inhibition of monoamine oxidase activity by cannabinoids","volume":"381","author":"Fi\u0161ar","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0495","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","article-title":"The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling","volume":"135","author":"Foga\u00e7a","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0500","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.bjp.0705608","article-title":"Oleamide: a member of the endocannabinoid family?","volume":"141","author":"Fowler","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0505","doi-asserted-by":"crossref","first-page":"15712","DOI":"10.1074\/jbc.M113.454843","article-title":"G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced up-regulation of serotonin 2A receptors","volume":"288","author":"Franklin","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0510","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2013.05.039","article-title":"Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats","volume":"548","author":"Franklin","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0515","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.phrs.2012.11.002","article-title":"Cannabinoid agonists increase the interaction between \u03b2-Arrestin 2 and ERK1\/2 and upregulate \u03b2-Arrestin 2 and 5-HT2A receptors","volume":"68","author":"Franklin","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0520","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.neubiorev.2019.09.036","article-title":"How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review","volume":"107","author":"Freeman","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0525","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1476-5381.1954.tb00848.x","article-title":"Drugs which antagonize 5-hydroxytryptamine","volume":"9","author":"Gaddum","year":"1954","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0530","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S2215-0366(19)30086-0","article-title":"Cannabis and psychosis: triangulating the evidence","volume":"6","author":"Gage","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0535","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.biopsych.2015.08.001","article-title":"Association between cannabis and psychosis: epidemiologic evidence","volume":"79","author":"Gage","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0540","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1007\/s12035-017-0833-7","article-title":"Cannabis users show enhanced expression of CB1-5HT2A receptor heteromers in olfactory neuroepithelium cells","volume":"55","author":"Galindo","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0545","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0550","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/ja00730a036","article-title":"Isolation and structure of delta1-tetrahydrocannabinol and other neutral cannabinoids from hashish","volume":"93","author":"Gaoni","year":"1971","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0555","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.euroneuro.2019.10.013","article-title":"Serotonin 5-HT 2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: selective biased agonism via G \u03b1 i1-proteins","volume":"29","author":"Garc\u00eda-Bea","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0560","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.pbb.2003.12.019","article-title":"Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test","volume":"77","author":"Genn","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0565","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130000573","article-title":"Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice","volume":"155","author":"Gingrich","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0575","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/phrs.1999.0560","article-title":"The cannabinoid agonist HU-210 modifies rat behavioural responses to novelty and stress","volume":"41","author":"Giuliani","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0580","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0585","first-page":"1362","article-title":"Agonist selective regulation of G-proteins by cannabinoid CB1 and CB2 receptors","volume":"56","author":"Glass","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0590","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0600","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0605","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0026-895X(24)26516-0","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide","volume":"57","author":"Gonsiorek","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0610","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1523\/JNEUROSCI.23-26-08836.2003","article-title":"Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex","volume":"23","author":"Gonzalez-Maeso","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0615","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonzalez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0620","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0625","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.eurpsy.2004.09.013","article-title":"Cannabis use and outcome of recent onset psychosis","volume":"20","author":"Grech","year":"2005","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0630","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjp.2008.207","article-title":"Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK","volume":"154","author":"Green","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0635","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","article-title":"Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents","volume":"57","author":"Griebel","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0640","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jnr.23180","article-title":"HTR2A-1438A\/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: a meta-analysis","volume":"91","author":"Gu","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0645","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimar\u00e3es","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0650","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/schbul\/sbaa038","article-title":"Altered signaling in CB1R-5-HT2AR heteromers in olfactory neuroepithelium cells of schizophrenia patients is modulated by cannabis use","volume":"46","author":"Guinart","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0655","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/wps.20629","article-title":"Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study","volume":"18","author":"Guloksuz","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0660","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cne.24066","article-title":"Anatomical characterization of the cannabinoid CB 1 receptor in cell-type-specific mutant mouse rescue models","volume":"525","author":"Guti\u00e9rrez-Rodr\u00edguez","year":"2017","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0665","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1389450053174550","article-title":"Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity","volume":"6","author":"Halford","year":"2005","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0670","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuroscience.2007.02.021","article-title":"Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice","volume":"146","author":"H\u00e4ring","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0675","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fnbeh.2015.00235","article-title":"Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability","volume":"9","author":"H\u00e4ring","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0680","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0685","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00008877-200509000-00006","article-title":"Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?","volume":"16","author":"Hill","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0690","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","article-title":"Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test","volume":"15","author":"Hill","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0695","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S1461145705005651","article-title":"Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment","volume":"9","author":"Hill","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0700","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.psyneuen.2007.02.003","article-title":"Estrogen recruits the endocannabinoid system to modulate emotionality","volume":"32","author":"Hill","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0705","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/02791072.1979.10472092","article-title":"How LSD originated","volume":"11","author":"Hofmann","year":"1979","journal-title":"J. Psychedelic Drugs"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0710","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/bja\/aen119","article-title":"Therapeutic potential of cannabis in pain medicine","volume":"101","author":"Hosking","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0715","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0090-6980(02)00060-6","article-title":"The cannabinoid receptors","volume":"68\u201369","author":"Howlett","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0720","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","article-title":"International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0725","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0730","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/exnr.2001.7792","article-title":"Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats","volume":"172","author":"Huitr\u00f3n-Res\u00e9ndiz","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0735","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.2174\/092986711798184253","article-title":"Serotonin and its receptors in the human CNS with new findings\u2014a mini review","volume":"18","author":"Hung","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0740","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/s41386-018-0076-y","article-title":"Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt\/mTOR pathway","volume":"43","author":"Ibarra-Lecue","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0745","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2018.07.009","article-title":"The endocannabinoid system in mental disorders: evidence from human brain studies","volume":"157","author":"Ibarra-Lecue","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0750","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1096-8628(19960216)67:1<103::AID-AJMG18>3.0.CO;2-S","article-title":"Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia","volume":"67","author":"Inayama","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0755","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.cell.2019.04.044","article-title":"Illuminating G-protein-coupling selectivity of GPCRs","volume":"177","author":"Inoue","year":"2019","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2021.01.004_bb9314","article-title":"Findings from the Global Burden of Disease Study 2017","author":"Institute for Health Metrics and Evaluation (IHME)","year":"2018","journal-title":"IHME"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0760","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03033218","article-title":"The serotonin1A receptor agonist 8-OHDPAT reverses \u03949-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats","volume":"6","author":"Inui","year":"2004","journal-title":"Neurotox. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0765","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1073\/pnas.95.2.735","article-title":"5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites","volume":"95","author":"Jakab","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0770","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1096-9861(20000214)417:3<337::AID-CNE7>3.0.CO;2-O","article-title":"Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex","volume":"417","author":"Jakab","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0775","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/nu8010056","article-title":"Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis","volume":"8","author":"Jenkins","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0780","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/npp.2008.71","article-title":"Stress impairs 5-HT2A receptor-mediated serotonergic facilitation of GABA release in juvenile rat basolateral amygdala","volume":"34","author":"Jiang","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0785","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.pnpbp.2009.04.010","article-title":"Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia-A postmortem study","volume":"33","author":"Kang","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0790","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0795","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bcp.2019.07.017","article-title":"Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPAR\u03b1","volume":"168","author":"Karwad","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0800","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0805","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple functions of endocannabinoid signaling in the brain","volume":"35","author":"Katona","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0810","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0306-4522(00)00286-4","article-title":"GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus","volume":"100","author":"Katona","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0815","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1369-1600.2012.00483.x","article-title":"Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT 1A receptors in the dorsal raphe nucleus","volume":"18","author":"Katsidoni","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0820","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/0269881105057516","article-title":"Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans","volume":"20","author":"Kedzior","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0825","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1126\/science.124.3225.723","article-title":"\u201cPermanent\u201d alteration of behavior in mice by chemical and psychological means","volume":"124","author":"Keller","year":"1956","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0830","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.110.173948","article-title":"Functional selectivity and biased receptor signaling","volume":"336","author":"Kenakin","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0835","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/mol.115.099192","article-title":"Biased agonism and biased allosteric modulation at the CB 1 cannabinoid receptor","volume":"88","author":"Khajehali","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0840","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42238-019-0012-y","article-title":"The therapeutic role of cannabidiol in mental health: a systematic review","volume":"2","author":"Khan","year":"2020","journal-title":"J. Cannabis Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0845","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.brs.2012.09.004","article-title":"Mapping brain regions in which deep brain stimulation affects schizophrenia-like behavior in two rat models of schizophrenia","volume":"6","author":"Klein","year":"2013","journal-title":"Brain Stimul."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0850","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1073\/pnas.1920162117","article-title":"Cannabis increases susceptibility to false memory","volume":"117","author":"Kloft","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0855","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.schres.2006.07.023","article-title":"Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness","volume":"88","author":"Koethe","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0860","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.2003.01921.x","article-title":"A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases","volume":"86","author":"Kurrasch-Orbaugh","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0865","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0870","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/archpsyc.1993.01820220066007","article-title":"Selective abnormalities of prefrontal serotonergic receptors in schizophrenia","volume":"50","author":"Laruelle","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0875","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bjp.0705607","article-title":"Oleamide is a selective endogenous agonist of rat and human CB 1 cannabinoid receptors","volume":"141","author":"Leggett","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0880","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130050884","article-title":"Effects of synthetic \u03949-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man","volume":"142","author":"Leweke","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0885","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.302.1.73","article-title":"Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo","volume":"302","author":"Lichtman","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0890","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0895","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0022-3565(25)13256-4","article-title":"Pharmacology and stereoselectivity of structurally novel cannabinoids in mice","volume":"247","author":"Little","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0900","first-page":"45","article-title":"Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways","volume":"36","author":"L\u00f3pez-Gim\u00e9nez","year":"2018"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0905","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0910","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-3223(02)01925-X","article-title":"Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia","volume":"54","author":"Ludewig","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0915","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.lfs.2005.05.011","article-title":"Cannabinoid receptor homo- and heterodimerization","volume":"77","author":"Mackie","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0920","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0896-6273(01)00375-0","article-title":"Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors","volume":"31","author":"Maejima","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0925","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.conb.2013.02.004","article-title":"Endocannabinoid system and drug addiction: new insights from mutant mice approaches","volume":"23","author":"Maldonado","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0930","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11894-015-0429-1","article-title":"The role of cannabinoids in regulation of nausea and vomiting, and visceral pain","volume":"17","author":"Malik","year":"2015","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0935","doi-asserted-by":"crossref","first-page":"E2492","DOI":"10.1073\/pnas.1323287111","article-title":"Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia","volume":"111","author":"Malkova","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0940","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjp.0701980","article-title":"Modulation of \u03949-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat","volume":"124","author":"Malone","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0945","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0091-3057(01)00567-6","article-title":"Involvement of somatodendritic 5-HT1A receptors in \u03949-tetrahydrocannabinol-induced hypothermia in the rat","volume":"69","author":"Malone","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0950","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.phrs.2007.09.003","article-title":"Enhancement of endocannabinoid signaling and the pharmacotherapy of depression","volume":"56","author":"Mangieri","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0955","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1017\/S0033291714000191","article-title":"Prognosis of schizophrenia in persons with and without a history of cannabis use","volume":"44","author":"Manrique-Garcia","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0960","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0197-0186(02)00093-1","article-title":"[3H]-ketanserin binding sites in different psychiatric disorders","volume":"42","author":"Marazziti","year":"2003","journal-title":"Neurochem. Int."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0965","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.neuropharm.2007.12.011","article-title":"Antagonistic cannabinoid CB1\/dopamine D2 receptor interactions in striatal CB1\/D2 heteromers. A combined neurochemical and behavioral analysis","volume":"54","author":"Marcellino","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0970","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008877-200402000-00003","article-title":"Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats","volume":"15","author":"Marco","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0975","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00213-020-05485-0","article-title":"Effects of combined 5-HT2A and cannabinoid receptor modulation on a schizophrenia-related prepulse inhibition deficit in mice","volume":"237","author":"Marques","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb0980","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jama.1898.92450160001002","article-title":"A contribution to the pharmacology of cannabis indica","volume":"XXXI","author":"Marshall","year":"1898","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0985","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","article-title":"Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs","volume":"40","author":"Martin","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0990","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fphar.2017.00744","article-title":"Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors","volume":"8","author":"Mart\u00ednez-Pinilla","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb0995","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drugalcdep.2010.11.020","article-title":"Failure to sustain prepulse inhibition in adolescent marijuana users","volume":"116","author":"Mathias","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1000","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1471-4159.2007.04961.x","article-title":"CB 1 knockout mice display impaired functionality of 5-HT 1A and 5-HT 2A\/C receptors","volume":"103","author":"Mato","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2004.12.059","article-title":"5-HT2A and muscarinic receptors in schizophrenia: a postmortem study","volume":"379","author":"Matsumoto","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1015","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biopsych.2019.07.034","article-title":"Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: a randomized, controlled experimental medicine trial","volume":"87","author":"Mayo","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FBP.0b013e3282ee7b44","article-title":"Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect","volume":"18","author":"McLaughlin","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.euroneuro.2012.01.004","article-title":"Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway","volume":"22","author":"McLaughlin","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1300\/J175v01n03_08","article-title":"Cannabis and cannabis extracts: greater than the sum of their parts?","volume":"1","author":"McPartland","year":"2001","journal-title":"J. Cannabis Ther."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0009-3084(02)00144-5","article-title":"Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects","volume":"121","author":"Mechoulam","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1045","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-X","article-title":"Hashish\u2014I","volume":"19","author":"Mechoulam","year":"1963","journal-title":"Tetrahedron"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1050","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/BF01959156","article-title":"Enantiomeric cannabinoids: stereospecificity of psychotropic activity","volume":"44","author":"Mechoulam","year":"1988","journal-title":"Experientia"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1065","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1476-5381.2009.00434.x","article-title":"Effect of the CB1 receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices","volume":"158","author":"Mendiguren","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1070","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1167\/iovs.18-24838","article-title":"\u03949-Tetrahydrocannabinol and cannabidiol differentially regulate intraocular pressure","volume":"59","author":"Miller","year":"2018","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/32937","article-title":"Rhodopsin-family receptors associate with small G-proteins to activate phospholipase D","volume":"392","author":"Mitchell","year":"1998","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00210-004-0921-x","article-title":"Differential effects of acute cannabinoid drug treatment, mediated by CB 1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain","volume":"369","author":"Moranta","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1369-1600.2008.00104.x","article-title":"The endocannabinoid system: emotion, learning and addiction","volume":"13","author":"Moreira","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1090","doi-asserted-by":"crossref","first-page":"18333","DOI":"10.1073\/pnas.1420285111","article-title":"Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training","volume":"111","author":"Morena","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1100","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.euroneuro.2012.10.006","article-title":"Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects","volume":"23","author":"Muguruza","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.euroneuro.2020.05.004","article-title":"Pimavanserin exhibits serotonin 5-HT2A receptor inverse agonism for G\u03b1i1- and neutral antagonism for G\u03b1q\/11-proteins in human brain cortex","volume":"36","author":"Muneta-Arrate","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pbb.2006.05.018","article-title":"Antipsychotics improve \u03949-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice","volume":"84","author":"Nagai","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002109900147","article-title":"Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB 1 receptors","volume":"361","author":"Nakazi","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2008.01.029","article-title":"Endocannabinoids mediate neuron-astrocyte communication","volume":"57","author":"Navarrete","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fpsyt.2020.00315","article-title":"Endocannabinoid system components as potential biomarkers in psychiatry","volume":"11","author":"Navarrete","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1140","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00213-015-4160-2","article-title":"Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use","volume":"233","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.euroneuro.2016.11.013","article-title":"Inverse agonists\u2014what do they mean for psychiatry?","volume":"27","author":"Nutt","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-2999(00)00832-3","article-title":"The antinociceptive effect induced by FR140423 is mediated through spinal 5-HT2A and 5-HT3 receptors","volume":"409","author":"Ochi","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2013.03.043","article-title":"Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain","volume":"709","author":"Ortega","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1160","first-page":"92","article-title":"Cannabinoid regulation of brain reward processing with an emphasis on the role of CB1 receptors: a step back into the future","volume":"5","author":"Panagis","year":"2014","journal-title":"Front. Psych."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.expneurol.2010.03.018","article-title":"The endocannabinoid system and psychiatric disorders","volume":"224","author":"Parolaro","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1170","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1471-4159.2006.04173.x","article-title":"Serotonin 5-HT 2A receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism","volume":"99","author":"Parrish","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2018.09.028","article-title":"Modality selective roles of pro-nociceptive spinal 5-HT2A and 5-HT3 receptors in normal and neuropathic states","volume":"143","author":"Patel","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.pa.15.040175.001203","article-title":"Pharmacology of marijuana","volume":"15","author":"Paton","year":"1975","journal-title":"Annu. Rev. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0306-4522(87)90327-7","article-title":"Serotonin receptors in the human brain\u2014IV. Autoradiographic mapping of serotonin-2 receptors","volume":"21","author":"Pazos","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1190","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00213-015-3945-7","article-title":"Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine","volume":"232","author":"Pedrazzi","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1195","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB 1 and CB 2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1200","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/jpet.117.244368","article-title":"Anti-inflammatory properties of cannabidiol, a nonpsychotropic cannabinoid, in experimental allergic contact dermatitis","volume":"365","author":"Petrosino","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1205","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.neuron.2017.02.002","article-title":"The CB1 receptor as the cornerstone of exostasis","volume":"93","author":"Piazza","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.expneurol.2013.12.021","article-title":"l-DOPA disrupts adenosine A2A\u2013cannabinoid CB1\u2013dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies","volume":"253","author":"Pinna","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1215","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1220","first-page":"72","article-title":"5-Hydroxytryptamine receptor subtypes and their modulators with therapeutic potentials","volume":"1","author":"Pithadia","year":"2009","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1225","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1021\/ja00952a624","article-title":"Additions and corrections\u2014chlorination studies of unsaturated materials in nonpolar media. IV. The ionic pathway for alkylated ethylenes. Products and relative reactivities","volume":"87","author":"Poutsma","year":"1965","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0920-9964(99)00150-4","article-title":"Serotonin2A receptors are reduced in the planum temporale from subjects with schizophrenia","volume":"44","author":"Pralong","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1235","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12035-011-8214-0","article-title":"Serotonin and prefrontal cortex function: neurons, networks, and circuits","volume":"44","author":"Puig","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1240","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nn.2369","article-title":"Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling","volume":"12","author":"Puighermanal","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1245","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: a review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1250","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00496-3","article-title":"Enhancement of memory in cannabinoid CB1 receptor knock-out mice","volume":"379","author":"Reibaud","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1255","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT 1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1260","first-page":"273","article-title":"Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action","volume":"18","author":"Reynolds","year":"1983","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1523\/JNEUROSCI.21-01-00109.2001","article-title":"Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens","volume":"21","author":"Robbe","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1270","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1124\/mol.64.5.1239","article-title":"Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT 2A receptor","volume":"64","author":"Robertson","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1275","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","article-title":"Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal","volume":"276","author":"Rodriguez de Fonseca","year":"1997","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1280","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.biopsych.2015.07.024","article-title":"The impact of exposure to cannabinoids in adolescence: insights from animal models","volume":"79","author":"Rubino","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1285","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cercor\/bhm161","article-title":"Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex","volume":"18","author":"Rubino","year":"2008","journal-title":"Cereb. Cortex"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1290","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1295","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1300","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.pnpbp.2007.01.012","article-title":"Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia","volume":"31","author":"S\u00e1iz","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1305","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pnpbp.2018.06.002","article-title":"Antidepressant-like effect induced by cannabidiol is dependent on brain serotonin levels","volume":"86","author":"Sales","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1310","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jnr.23198","article-title":"Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia","volume":"91","author":"Santini","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1315","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1320","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1523\/JNEUROSCI.1665-10.2010","article-title":"Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a \u03b2-arrestin2\/Src\/Akt signaling complex in vivo","volume":"30","author":"Schmid","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1325","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1073\/pnas.0708862105","article-title":"Agonist-directed signaling of the serotonin 2A receptor depends on -arrestin-2 interactions in vivo","volume":"105","author":"Schmid","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1330","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1335","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1300225","article-title":"Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats","volume":"28","author":"Schneider","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1340","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(83)90729-1","article-title":"Characterization and regional distribution of serotonin S2-receptors in human brain","volume":"276","author":"Schotte","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)60289-5","article-title":"Transport and metabolism of glutamate and GABA in neurons and glial cells","volume":"22","author":"Schousboe","year":"1981","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1350","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1038\/tp.2015.115","article-title":"Schizophrenia: a tale of two critical periods for prefrontal cortical development","volume":"5","author":"Selemon","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1355","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neubiorev.2014.06.005","article-title":"Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies","volume":"45","author":"Selvaraj","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1360","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/acps.13081","article-title":"Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort","volume":"140","author":"Seti\u00e9n-Suero","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1365","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2010.09.039","article-title":"Systemic cannabinoids produce CB1-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT7 and 5-HT2A receptors","volume":"649","author":"Seyrek","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1370","doi-asserted-by":"crossref","first-page":"e1002473","DOI":"10.1371\/journal.pcbi.1002473","article-title":"Ligand-dependent conformations and dynamics of the serotonin 5-HT2A receptor determine its activation and membrane-driven oligomerization properties","volume":"8","author":"Shan","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1375","doi-asserted-by":"crossref","first-page":"108155","DOI":"10.1016\/j.neuropharm.2020.108155","article-title":"Central 5-HT receptors and their function; present and future","volume":"177","author":"Sharp","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1380","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1073\/pnas.0600585103","article-title":"p90 ribosomal S6 kinase 2 exerts a tonic brake on G-protein-coupled receptor signaling","volume":"103","author":"Sheffler","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1385","doi-asserted-by":"crossref","first-page":"18150","DOI":"10.1073\/pnas.1113444108","article-title":"The major central endocannabinoid directly acts at GABA(A) receptors","volume":"108","author":"Sigel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1390","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neuropharm.2018.03.036","article-title":"Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: a translational study in rats and humans","volume":"135","author":"Skosnik","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1395","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0026-895X(25)10254-X","article-title":"Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase","volume":"48","author":"Slipetz","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1400","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuint.2003.08.009","article-title":"Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex\u2014involvement of Na+\/K+-ATPase","volume":"44","author":"Steffens","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1405","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/1570159X15666170424120802","article-title":"TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling","volume":"16","author":"Storozhuk","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1410","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1074\/jbc.M805705200","article-title":"Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT 2A) serotonin receptor, thereby modulating 5-HT 2A signaling","volume":"284","author":"Strachan","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1415","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1124\/mol.109.061440","article-title":"Genetic deletion of p90 ribosomal S6 kinase 2 alters patterns of 5-hydroxytryptamine 2A serotonin receptor functional selectivity","volume":"77","author":"Strachan","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1420","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrg3240","article-title":"Genetic architectures of psychiatric disorders: the emerging picture and its implications","volume":"13","author":"Sullivan","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1425","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1994.03950020063007","article-title":"Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients","volume":"51","author":"Swerdlow","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1430","doi-asserted-by":"crossref","first-page":"14115","DOI":"10.1073\/pnas.94.25.14115","article-title":"Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide","volume":"94","author":"Thomas","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1435","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005053-199008000-00001","article-title":"Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences","volume":"178","author":"Tien","year":"1990","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1440","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.febslet.2009.04.031","article-title":"Transient receptor potential vanilloid-1 signaling inhibits differentiation and activation of human dendritic cells","volume":"583","author":"T\u00f3th","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1445","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1450","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions","volume":"138","author":"Tzavara","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1455","first-page":"1","article-title":"Global overview of drug demand and supply","volume":"2018","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2017","journal-title":"World Drug Rep."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2012.01.002","article-title":"Cannabinoid receptor signaling and modulation of monoamines: implications for psychiatric and neurological disorders","volume":"38","author":"Van Bockstaele","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1465","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwf043","article-title":"Cannabis use and psychosis: a longitudinal population-based study","volume":"156","author":"van Os","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1470","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nature09563","article-title":"The environment and schizophrenia","volume":"468","author":"van Os","year":"2010","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1475","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1369-1600.2007.00065.x","article-title":"Effect of cannabinoids on platelet serotonin uptake","volume":"12","author":"Velenovsk\u00e1","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1480","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bjp.0703051","article-title":"Stereoselective modulatory actions of oleamide on GABA A receptors and voltage-gated Na+ channels in vitro: a putative endogenous ligand for depressant drug sites in CNS","volume":"129","author":"Verdon","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1485","doi-asserted-by":"crossref","first-page":"e1002194","DOI":"10.1371\/journal.pbio.1002194","article-title":"Cognitive impairment induced by delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors","volume":"13","author":"Vi\u00f1als","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1490","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1495","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.HYP.33.1.429","article-title":"Mesenteric vasodilation mediated by endothelial anandamide receptors","volume":"33","author":"Wagner","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1500","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.111.004697","article-title":"Serotonin and blood pressure regulation","volume":"64","author":"Watts","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1505","first-page":"36","article-title":"Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice","volume":"4","author":"Weber","year":"2010","journal-title":"Front. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1510","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2008.11.081","article-title":"Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment","volume":"1253","author":"Wegener","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1515","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1520","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1192\/bjp.bp.105.012179","article-title":"Self-reported psychotic symptoms in the general population","volume":"188","author":"Wiles","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1525","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0031-9384(98)00170-X","article-title":"Hyperphagia in pre-fed rats following oral \u03b49-THC","volume":"65","author":"Williams","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1530","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1523\/JNEUROSCI.22-07-02843.2002","article-title":"The physiological role of 5-HT 2A receptors in working memory","volume":"22","author":"Williams","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1535","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3565(24)36840-5","article-title":"Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats","volume":"282","author":"Willins","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1540","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2021.01.004_bb1545","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-200509000-00005","article-title":"A role for cannabinoid CB1 receptors in mood and anxiety disorders","volume":"16","author":"Witkin","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1550","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","article-title":"Mechanisms of signalling and biased agonism in G-protein-coupled receptors","volume":"19","author":"Wootten","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1555","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41401-018-0051-5","article-title":"Integrating endocannabinoid signaling in the regulation of anxiety and depression","volume":"40","author":"Yin","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1560","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1565","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2021.01.004_bb1570","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"}],"container-title":["Progress in Brain Research","5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612321000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612321000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:49:13Z","timestamp":1753260553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612321000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128245675"],"references-count":314,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2021.01.004","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}